1	Calcineurin	Calcineurin	_	_	_	_	_	_	_
2	acts	act	_	_	_	_	_	_	_
3	in	in	_	_	_	_	_	_	_
4	synergy	synergy	_	_	_	_	_	_	_
5	with	with	_	_	_	_	_	_	_
6	PMA	PMA	_	_	_	_	_	_	_
7	to	to	_	_	_	_	_	_	_
8	inactivate	inactivate	_	_	_	_	_	_	_
9	I	i	_	_	_	_	_	_	_
10	kappa	kappa	_	_	_	_	_	_	_
11	B/MAD3	b/mad3	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	an	an	_	_	_	_	_	_	_
14	inhibitor	inhibitor	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	NF-kappa	NF-kappa	_	_	_	_	_	_	_
17	B.	B.	_	_	_	_	_	_	_
18	The	the	_	_	_	_	_	_	_
19	interleukin-2	interleukin-2	_	_	_	_	_	_	_
20	(	(	_	_	_	_	_	_	_
21	IL-2	il-2	_	_	_	_	_	_	_
22	)	)	_	_	_	_	_	_	_
23	promoter	promoter	_	_	_	_	_	_	_
24	consists	consist	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	several	several	_	_	_	_	_	_	_
27	independent	independent	_	_	_	_	_	_	_
28	T	t	_	_	_	_	_	_	_
29	cell	cell	_	_	_	_	_	_	_
30	receptor	receptor	_	_	_	_	_	_	_
31	(	(	_	_	_	_	_	_	_
32	TcR	TcR	_	_	_	_	_	_	_
33	)	)	_	_	_	_	_	_	_
34	responsive	responsive	_	_	_	_	_	_	_
35	elements	element	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	induction	induction	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	promoters	promoter	_	_	_	_	_	_	_
5	dependent	dependent	_	_	_	_	_	_	_
6	on	on	_	_	_	_	_	_	_
7	these	these	_	_	_	_	_	_	_
8	elements	element	_	_	_	_	_	_	_
9	is	be	_	_	_	_	_	_	_
10	inhibitable	inhibitable	_	_	_	_	_	_	_
11	by	by	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	immunosuppressants	immunosuppressant	_	_	_	_	_	_	_
14	cyclosporin	cyclosporin	_	_	_	_	_	_	_
15	A	a	_	_	_	_	_	_	_
16	(	(	_	_	_	_	_	_	_
17	CsA	CsA	_	_	_	_	_	_	_
18	)	)	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	tacrolimus	tacrolimus	_	_	_	_	_	_	_
21	(	(	_	_	_	_	_	_	_
22	FK-506	FK-506	_	_	_	_	_	_	_
23	)	)	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	Calcineurin	Calcineurin	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	a	a	_	_	_	_	_	_	_
4	Ca2+/calmodulin-dependent	ca2+/calmodulin-dependent	_	_	_	_	_	_	_
5	protein	protein	_	_	_	_	_	_	_
6	phosphatase	phosphatase	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	is	be	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	FK-506-	fk-506-	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	CsA-sensitive	csa-sensitive	_	_	_	_	_	_	_
13	enzyme	enzyme	_	_	_	_	_	_	_
14	required	require	_	_	_	_	_	_	_
15	for	for	_	_	_	_	_	_	_
16	TcR	TcR	_	_	_	_	_	_	_
17	mediated	mediated	_	_	_	_	_	_	_
18	activation	activation	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	IL-2	il-2	_	_	_	_	_	_	_
22	promoter	promoter	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	report	report	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	a	a	_	_	_	_	_	_	_
5	constitutively	constitutively	_	_	_	_	_	_	_
6	active	active	_	_	_	_	_	_	_
7	form	form	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	calcineurin	calcineurin	_	_	_	_	_	_	_
10	partially	partially	_	_	_	_	_	_	_
11	substitutes	substitute	_	_	_	_	_	_	_
12	for	for	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	Ca2+	ca2+	_	_	_	_	_	_	_
15	co-stimulus	co-stimulus	_	_	_	_	_	_	_
16	required	require	_	_	_	_	_	_	_
17	to	to	_	_	_	_	_	_	_
18	activate	activate	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	IL-2	il-2	_	_	_	_	_	_	_
21	promoter	promoter	_	_	_	_	_	_	_
22	elements	element	_	_	_	_	_	_	_
23	IL-2A	il-2a	_	_	_	_	_	_	_
24	(	(	_	_	_	_	_	_	_
25	which	which	_	_	_	_	_	_	_
26	binds	bind	_	_	_	_	_	_	_
27	the	the	_	_	_	_	_	_	_
28	factors	factor	_	_	_	_	_	_	_
29	OAP	OAP	_	_	_	_	_	_	_
30	and	and	_	_	_	_	_	_	_
31	Oct-1	Oct-1	_	_	_	_	_	_	_
32	)	)	_	_	_	_	_	_	_
33	and	and	_	_	_	_	_	_	_
34	IL-2E	IL-2E	_	_	_	_	_	_	_
35	(	(	_	_	_	_	_	_	_
36	which	which	_	_	_	_	_	_	_
37	binds	bind	_	_	_	_	_	_	_
38	NF-AT	NF-AT	_	_	_	_	_	_	_
39	)	)	_	_	_	_	_	_	_
40	,	,	_	_	_	_	_	_	_
41	and	and	_	_	_	_	_	_	_
42	completely	completely	_	_	_	_	_	_	_
43	substitutes	substitute	_	_	_	_	_	_	_
44	for	for	_	_	_	_	_	_	_
45	the	the	_	_	_	_	_	_	_
46	Ca2+	ca2+	_	_	_	_	_	_	_
47	co-stimulus	co-stimulus	_	_	_	_	_	_	_
48	required	require	_	_	_	_	_	_	_
49	to	to	_	_	_	_	_	_	_
50	stimulate	stimulate	_	_	_	_	_	_	_
51	an	an	_	_	_	_	_	_	_
52	NF-kappa	NF-kappa	_	_	_	_	_	_	_
53	B-dependent	b-dependent	_	_	_	_	_	_	_
54	element	element	_	_	_	_	_	_	_
55	.	.	_	_	_	_	_	_	_

1	Calcineurin	Calcineurin	_	_	_	_	_	_	_
2	stimulates	stimulate	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	NF-kappa	NF-kappa	_	_	_	_	_	_	_
5	B	B	_	_	_	_	_	_	_
6	element	element	_	_	_	_	_	_	_
7	by	by	_	_	_	_	_	_	_
8	enhancing	enhance	_	_	_	_	_	_	_
9	inactivation	inactivation	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	I	i	_	_	_	_	_	_	_
12	kappa	kappa	_	_	_	_	_	_	_
13	B/MAD3	b/mad3	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	an	an	_	_	_	_	_	_	_
16	inhibitor	inhibitor	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	NF-kappa	NF-kappa	_	_	_	_	_	_	_
19	B	B	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	thereby	thereby	_	_	_	_	_	_	_
22	increasing	increase	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	amount	amount	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	nuclear	nuclear	_	_	_	_	_	_	_
27	NF-kappa	NF-kappa	_	_	_	_	_	_	_
28	B	B	_	_	_	_	_	_	_
29	DNA	DNA	_	_	_	_	_	_	_
30	binding	binding	_	_	_	_	_	_	_
31	activity	activity	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	data	datum	_	_	_	_	_	_	_
3	provide	provide	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	first	first	_	_	_	_	_	_	_
6	demonstration	demonstration	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	vivo	vivo	_	_	_	_	_	_	_
9	that	that	_	_	_	_	_	_	_
10	activation	activation	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	a	a	_	_	_	_	_	_	_
13	protein	protein	_	_	_	_	_	_	_
14	phosphatase	phosphatase	_	_	_	_	_	_	_
15	can	can	_	_	_	_	_	_	_
16	inactivate	inactivate	_	_	_	_	_	_	_
17	I	i	_	_	_	_	_	_	_
18	kappa	kappa	_	_	_	_	_	_	_
19	B	B	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	suggest	suggest	_	_	_	_	_	_	_
23	one	one	_	_	_	_	_	_	_
24	possible	possible	_	_	_	_	_	_	_
25	explanation	explanation	_	_	_	_	_	_	_
26	for	for	_	_	_	_	_	_	_
27	mechanism-based	mechanism-based	_	_	_	_	_	_	_
28	toxicities	toxicity	_	_	_	_	_	_	_
29	associated	associate	_	_	_	_	_	_	_
30	with	with	_	_	_	_	_	_	_
31	FK-506	FK-506	_	_	_	_	_	_	_
32	and	and	_	_	_	_	_	_	_
33	CsA	CsA	_	_	_	_	_	_	_
34	by	by	_	_	_	_	_	_	_
35	demonstrating	demonstrate	_	_	_	_	_	_	_
36	that	that	_	_	_	_	_	_	_
37	these	these	_	_	_	_	_	_	_
38	drugs	drug	_	_	_	_	_	_	_
39	can	can	_	_	_	_	_	_	_
40	inhibit	inhibit	_	_	_	_	_	_	_
41	the	the	_	_	_	_	_	_	_
42	calcineurin-dependent	calcineurin-dependent	_	_	_	_	_	_	_
43	activation	activation	_	_	_	_	_	_	_
44	of	of	_	_	_	_	_	_	_
45	a	a	_	_	_	_	_	_	_
46	virtually	virtually	_	_	_	_	_	_	_
47	ubiquitous	ubiquitous	_	_	_	_	_	_	_
48	transcription	transcription	_	_	_	_	_	_	_
49	factor	factor	_	_	_	_	_	_	_
50	.	.	_	_	_	_	_	_	_

